Optimizing antimicrobial therapy for gram-positive bloodstream infections in patients on hemodialysis

Amy Barton Pai1, Manjunath P Pai

  • 1Department of Pharmacy and Nephrology, University of New Mexico College of Pharmacy, Albuquerque, NM 87131, USA. abpai@salud.unm.edu

Insights

Gram-positive infections are common in hemodialysis patients, leading to resistance against crucial antibiotics like vancomycin. Understanding antimicrobial pharmacokinetics is vital for effective treatment and avoiding side effects.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Pharmacology

Background:

  • Gram-positive bacterial infections are a significant cause of illness and death in hemodialysis patients.
  • Widespread antimicrobial use in this population has led to increasing resistance, particularly in Enterococcus spp. and Staphylococcus aureus.
  • Emerging resistance to vancomycin and newer agents like linezolid and daptomycin poses a therapeutic challenge.

Purpose of the Study:

  • To review mechanisms of antimicrobial resistance in common gram-positive organisms.
  • To discuss pharmacokinetic and pharmacodynamic principles of key antimicrobial agents.
  • To explore the application of these principles in treating bloodstream infections in hemodialysis patients.

Main Methods:

  • Literature review focusing on antimicrobial resistance mechanisms.
  • Analysis of pharmacokinetic and pharmacodynamic data for selected antibiotics.
  • Discussion of clinical applications in hemodialysis patients.

Main Results:

  • Gram-positive organisms, including Enterococcus spp. and Staphylococcus aureus, exhibit increasing resistance to vancomycin and newer antibiotics.
  • Antimicrobial pharmacokinetics and pharmacodynamics are significantly altered in patients with chronic kidney disease.
  • Understanding these altered profiles is crucial for optimizing treatment efficacy.

Conclusions:

  • Antimicrobial resistance in gram-positive pathogens is a growing concern in hemodialysis.
  • Tailoring antimicrobial therapy based on pharmacokinetic and pharmacodynamic principles is essential for effective treatment and minimizing adverse events.
  • Further research and careful drug selection are needed to manage infections in this vulnerable patient group.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...